J. Gram

J. Gram, J. Sidelmann, J. Thorn, 2016, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Interrelationship between coagulant activity and tissue‐type plasminogen activator (t‐PA) system in acute ischaemic heart disease. Possible role of the endothelium

J. Jespersen, C. Kluft, J. Gram, 1990, Journal of internal medicine.

Acquired activated protein-C resistance

J. Jespersen, P. Meijer, J. Gram, 1999, The Lancet.

Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients.

J. Jespersen, J. Gram, 1992, Metabolism: clinical and experimental.

Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS)

L. Rejnmark, S. Kristensen, J. Jespersen, 2006, Thrombosis and Haemostasis.

Subclinical Hypothyroidism, Dyslipidemia, and Cardiovascular Risk

J. Kvetny, J. Gram, 2011 .

The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors

J. Jespersen, L. Nilas, J. Gram, 2008, Climacteric : the journal of the International Menopause Society.

Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo

J. Gram, J. Graversen, Y. Palarasah, 2022, Frontiers in Cardiovascular Medicine.

Fast form alpha-2-macroglobulin - A marker for protease activation in plasma exposed to artificial surfaces.

K. Skjoedt, J. Gram, Y. Palarasah, 2017, Clinical biochemistry.

Presence of C1-Inhibitor Polymers in a Subset of Patients Suffering from Hereditary Angioedema

J. Gram, C. Drouet, J. Sidelmann, 2014, PloS one.

Increased fibrinolytic potential induced by gliclazide in types I and II diabetic patients.

J. Jespersen, J. Gram, 1991, The American journal of medicine.

Deviations in factor XII-dependent plasminogen activator activity in relation to ischaemic heart disease and age

K. K. Thomsen, J. Jespersen, C. Kluft, 1992 .

Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients.

J. Jespersen, A. Kold, J. Gram, 1988, Metabolism: clinical and experimental.

The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intima.

J. Jespersen, J. Gram, S. Munkvad, 1993, Danish medical bulletin.

A Selective Depression of Tissue Plasminogen Activator (t-PA) Activity in Euglobulins Characterises a Risk Group Among Survivors of Acute Myocardial Infarction

J. Jespersen, J. Gram, 1987, Thrombosis and Haemostasis.

Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis

J. Gram, J. Sidelmann, A. Münster, 2018, Seminars in Thrombosis and Hemostasis.

A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.

J. Jespersen, J. Gram, S. Munkvad, 1990, European heart journal.

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy.

P. Rossing, J. Jespersen, C. Kluft, 1996, Thrombosis research.

The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum.

J. Jespersen, E. Bladbjerg, J. Gram, 1995, Scandinavian journal of clinical and laboratory investigation.

FIBRINOLYSIS AND RECURRENCE OF MYOCARDIAL INFARCTION

J. Kostis, J. Jespersen, J. Gram, 1987, The Lancet.

Enhanced Effective Fibrinolysis following the Neutralization of Heparin in Open Heart Surgery Increases the Risk of Post-Surgical Bleeding

J. Jespersen, J. Gram, H. Bruhn, 1990, Thrombosis and Haemostasis.

Does protamine chloride neutralize low molecular weight heparin sufficiently?

J. Gram, H. Bruhn, S. Mercker, 1988, Thrombosis research.

Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis

J. Jespersen, E. Bladbjerg, J. Gram, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Subclinical hypothyroidism is associated with a low‐grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years

J. Kvetny, E. Bladbjerg, J. Gram, 2004, Clinical endocrinology.

Fibrin clot structure in patients with end-stage renal disease

K. Esbensen, J. Gram, R. Ariëns, 2007, Thrombosis and Haemostasis.

Various approaches to standardization and the importance of measurement accuracy

P. Declerck, J. Jespersen, C. Kluft, 1996 .

Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients.

J. Jespersen, J. Gram, R. Smith Pedersen, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Depression of Tissue Plasminogen Activator (t-PA) Activity and Rise of t-PA Inhibition and Acute Phase Reactants in Blood of Patients with Acute Myocardial Infarction (AMI)

J. Jespersen, C. Kluft, J. Gram, 1987, Thrombosis and Haemostasis.

Effect of inhaled heparin on lung function and coagulation in healthy volunteers

K. E. Bendstrup, J. Gram, J. I. Jensen, 2002, European Respiratory Journal.

Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled study.

J. Jespersen, J. Gram, S. Munkvad, 1991, Lymphokine and cytokine research.

Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.

J. Jespersen, J. Gram, L. F. Andersen, 1999, American journal of obstetrics and gynecology.

Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA).

E. Bendstrup, J. Gram, A. Münster, 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma.

J. Jespersen, J. Gram, J. Sidelmann, 1990, Clinical chemistry.

Reduction of infarct size estimated enzymatically in patients with acute myocardial infarction after treatment with recombinant tissue type plasminogen activator or after spontaneous coronary recanalisation: A randomised, placebo controlled study

J. Jespersen, P. Grande, J. Gram, 1990 .

DIAGNOSIS OF DEEP-VEIN THROMBOSIS

J. Jespersen, T. Astrup, J. Gram, 1984, The Lancet.

Anabolic–Androgenic Steroid Abuse Impairs Fibrin Clot Lysis

J. Gram, J. Sidelmann, C. Kistorp, 2020, Seminars in Thrombosis and Hemostasis.

Tissue thromboplastin induces rapid inhibition of fibrinolysis in rabbits

J. Gram, T. Tvedskov, H. Vad, 1996 .

The influence of venepuncture, mixing and separation of blood on the measurement of thrombin-antithrombin-III-complex and plasminogen activator inhibitor

J. Gram, J. Sidelmann, 1990 .

Angiotensin-converting enzyme inhibitor trandolapril does not affect C-reactive protein levels in myocardial infarction patients.

J. Jespersen, C. Kluft, M. D. de Maat, 2003, Circulation.

Does long‐term angiotensin converting enzyme inhibition affect the concentration of tissue‐type plasminogen activator‐plasminogen activator inhibitor‐1 in the blood of patients with a previous myocardial infarction

X. Jeunemaître, J. Jespersen, J. Gram, 1997, Coronary artery disease.

Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse®) in resting healthy subjects is proportional to the arterial concentration

J. Jespersen, J. Gram, K. Tønnesen, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Contact activation‐induced complex formation between complement factor H and coagulation factor XIIa

J. Gram, J. Graversen, Y. Palarasah, 2020, Journal of thrombosis and haemostasis : JTH.

Thrombophilia screening in the acute phase of deep venous thrombosis

J. Gram, J. Sidelmann, A. Münster, 2009, Scandinavian journal of clinical and laboratory investigation.

Increased fibrin formation in blood in women above the age of 30 who are both oral contraceptive users and smokers

J. Jespersen, J. Gram, 1996 .

Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen.

J. Jespersen, J. Gram, S. Munkvad, 1990, American journal of obstetrics and gynecology.

Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapy.

J. Jespersen, C. Kluft, J. Gram, 1991, Journal of the American College of Cardiology.

Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study.

J. Jespersen, J. Gram, S. Munkvad, 1991, Scandinavian journal of clinical and laboratory investigation.

Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or both.

J. Jespersen, J. Gram, T. D. Poulsen, 1988, Journal of medicine.

Regulation of tissue‐type plasminogen activator‐mediated fibrinolysis by plasminogen activator inhibitor type‐1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics

J. Jespersen, J. Gram, H. Bagger, 1994, Coronary artery disease.

On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.

J. Jespersen, C. Kluft, J. Gram, 2009, Acta medica Scandinavica.

Longevity Is Independent of Common Variations in Genes Associated with Cardiovascular Risk

S. Kristensen, J. Jespersen, M. D. de Maat, 1999, Thrombosis and Haemostasis.

SAMeTT(2)R(2) does not predict time in therapeutic range of the international normalized ratio in patients attending a high-quality anticoagulation clinic.

E. Bladbjerg, J. Gram, M. Bor, 2014, Chest.

No Effect of Unfractioned or Low Molecular Weight Heparin Treatment on Markers of Vascular Wall and Hemostatic Function in Incipient Diabetic Nephropathy

J. Jespersen, C. Kluft, T. Deckert, 1997, Diabetes Care.

The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitus

P. Rossing, J. Jespersen, C. Kluft, 1994 .

Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-III.

J. Jespersen, T. Astrup, C. Kluft, 1985, American journal of clinical pathology.

Plasminogen Activator Inhibitor Type-1 Determines Plasmin Formation in Patients with Ischaemic Heart Disease

J. Jespersen, J. Gram, O. Pedersen, 1995, Thrombosis and Haemostasis.

Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age

S. Feddersen, J. Gram, M. Nybo, 2013, Scandinavian journal of clinical and laboratory investigation.

A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasma

J. Jespersen, J. Gram, 1987 .

Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients

A. Leppin, E. Bladbjerg, J. Gram, 2012, Thrombosis and Haemostasis.

Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis.

J. Gram, K. Zurborn, H. Bruhn, 1991, Scandinavian journal of gastroenterology.

Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non‐Hodgkin's lymphomas and acute leukemias

J. Gram, H. Pelzer, K. Zurborn, 1991, European journal of haematology.

Chronobiology of coronary risk markers in Greenland Eskimos: a comparative study with Caucasians residing in the same Arctic area.

J. Jespersen, C. Kluft, J. Gram, 1991, Chronobiology international.

Circadian variations of extrinsic fibrinolytic components in blood from eskimos

J. Jespersen, C. Kluft, J. Gram, 1990 .

The risk of thrombosis in hereditary protein S deficiency in a Scandinavian family

R. Bertina, J. Jespersen, J. Gram, 1989 .

A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.

J. Jespersen, T. Astrup, J. Gram, 1986, Thrombosis research.

The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition.

J. Jespersen, T. Astrup, J. Gram, 1986, Thrombosis research.

Influence of Plasma Platelets on Activated Protein C Resistance Assay

J. Jespersen, J. Gram, J. Sidelmann, 1995, Thrombosis and Haemostasis.

Fibrinolytic Changes in Women with Preeclampsia

J. Gram, Y. Palarasah, J. S. Jørgensen, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome

J. Jespersen, J. Gram, A. Münster, 1999 .

A new automated method for continuous registration of factor VII activation in vitro. Activation is accelerated by the concentration of factor VII and the activity state of the protein.

J. Jespersen, E. Bladbjerg, J. Gram, 1994, Scandinavian journal of clinical and laboratory investigation.

Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter plates.

J. Jespersen, J. Gram, J. Sidelmann, 1995, Clinical chemistry.

Investigations of coagulation system and fibrinolysis in patients with disseminated adenocarcinomas and non-Hodgkin's lymphomas.

J. Gram, K. Zurborn, H. Bruhn, 1990, Oncology.

Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines

J. Gram, M. Bor, J. Sidelmann, 2018, Lupus.

World distribution of factor V Leiden mutation

P. Reitsma, P. Morel, J. Jespersen, 1996, The Lancet.

Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy.

P. Rossing, J. Jespersen, H. Parving, 2001, Scandinavian journal of clinical and laboratory investigation.

Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen

J. Jespersen, J. Gram, S. Munkvad, 1991 .

Characterization of Plasminogen Activators in Unstimulated and Stimulated Human Whole Saliva

J. Jespersen, J. Gram, S. Sindet‐Pedersen, 1987, Journal of dental research.

Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.

J. Jespersen, J. Gram, J. Nielsen, 1997, British journal of urology.

The Possible Role of Oral Epithelial Cells in Tissue-type Plasminogen Activator-related Fibrinolysis in Human Saliva

J. Jespersen, J. Gram, S. Sindet‐Pedersen, 1990, Journal of dental research.

Factor XII dependent fibrinolytic activity is decreased in the acute phase of myocardial or cerebral infarction

J. Jespersen, C. Kluft, M. Spannagl, 1996 .

Evidence for a Role of Factor XII‐dependent Fibrinolysis in Cardiovascular Diseases

J. Jespersen, C. Kluft, J. Gram, 1992, Annals of the New York Academy of Sciences.

Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.

J. Jespersen, C. Kluft, J. Gram, 1991, Journal of the American College of Cardiology.

The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.

J. Jespersen, C. Kluft, J. Gram, 1997, Clinica chimica acta; international journal of clinical chemistry.

A Functional Plasminogen Assay Utilizing the Potentiating Effect of Fibrinogen to Correct for the Overestimation of Plasminogen in Pathological Plasma Samples

J. Jespersen, J. Gram, 1985, Thrombosis and Haemostasis.

Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseases.

J. Jespersen, J. Gram, S. Munkvad, 1989, Scandinavian journal of rheumatology.

[The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors].

J. Gram, B. Bewig, E. Rohwedder, 1989, Medizinische Klinik.

Effects of an oral antidiabetic drug (gliclazide) on inhibition of coagulation and fibrinolysis studied in insulin-treated diabetic patients (type I)

J. Jespersen, A. Kold, J. Gram, 1989 .

Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III.

J. Jespersen, J. Gram, 1989, Clinical chemistry.

Neurophysiological variables and fibrinolysis in insulin-dependent diabetes treated with an aldose reductase inhibitor or placebo. A double-blind randomized study.

J. Jespersen, J. Gram, J. Christensen, 1986, Haemostasis.

Mean transit times and the sites of synthesis and catabolism of tissue plasminogen activator and plasminogen activator inhibitor type 1 in young subjects

J. Jespersen, J. Gram, K. Tønnesen, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Procoagulant activity and intimal dysfunction in IDDM

P. Rossing, J. Jespersen, C. Kluft, 2006, Diabetologia.

Protein C Activation during the Initial Phase of Experimental Acute Pancreatitis in the Rabbit

E. Bladbjerg, J. Gram, N. O. Jacobsen, 2000, Digestive Surgery.

A study of the transient increase in blood fibrinolytic activity during haemodialysis

J. Jespersen, T. Astrup, J. Gram, 1987 .

Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma.

J. Jespersen, J. Gram, M. Rånby, 1990, Clinical chemistry.

Anticoagulant Properties of Rabbit Lungs in Tissue Thromboplastin-induced Intravascular Coagulation

J. Jespersen, J. Gram, H. Vad, 1997, Thrombosis and Haemostasis.

Elevated Plasma Concentrations of Fibrinogen May Cause an Overestimation of Functional Plasminogen

J. Jespersen, J. Gram, S. Munkvad, 1989, Thrombosis and Haemostasis.

Sex difference in fibrin clot lysability: Association with coronary plaque composition.

D. Dey, B. Nørgaard, J. Gram, 2019, Thrombosis research.

Introduction to laboratory assays in haemostasis and thrombosis

J. Gram, J. Jespersen, J. Jespersen, 1999 .

Does Low Protein Concentration of Tissue-type Plasminogen Activator Predict a Low Risk of Spontaneous Deep Vein Thrombosis?

J. Jespersen, J. Gram, J. Sidelmann, 1995, Thrombosis and Haemostasis.

IncreasedConcentrationsof Heparin CofactorII in DiabeticPatients , and PossibleEffectson ThrombinInhibitionAssay of AntithrombinIII

J. Gram, 2004 .

Modification of the Immediate Plasmin Inhibition Assay to Secure Linearity of the Reference Curve with the Chromogenic Substrate S-2251

J. Jespersen, J. Gram, J. Sidelmann, 1984, Thrombosis and Haemostasis.

The assay of factor Xa on a centrifugal analyzer.

J. Jespersen, J. Gram, J. Sidelmann, 1984, Thrombosis research.

On the Significance of Antithrombin-III, α2-Macroglobulin, α2-Antiplasmin, Histidine-Rich Glycoprotein, and Protein C in Patients with Acute Myocardial Infarction and Deep Vein Thrombosis

J. Jespersen, J. Gram, 1985, Thrombosis and Haemostasis.

Studies of the initial anticoagulant response in tissue-thromboplastin induced intravascular coagulation.

J. Gram, T. Tvedskov, K. Bendix-Hansen, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Reactive coagulation induced by plasmin in patients treated with recombinant tissue‐type plasminogen activator

J. Jespersen, F. Leebeek, C. Kluft, 1993, Coronary artery disease.

Increased Concentrations of HeparinCofactorII in DiabeticPatients,andPossibleEffectson Thrombin Inhibition Assayof Antithrombin III

J. Gram, 1989 .

Effect of Anabolic–Androgenic Steroid Abuse on the Contact Activation System

J. Gram, Y. Palarasah, J. Sidelmann, 2021, Thrombosis and Haemostasis.

C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.

J. Gram, J. Sidelmann, S. Hansen, 2015, Biochimica et biophysica acta.

Calibrated kallikrein generation in human plasma.

L. Olsen, J. Gram, Y. Palarasah, 2016, Clinical biochemistry.

Depressed Kallikrein Generation in Women With Preeclampsia: A Matched Cross-Sectional Study

J. Gram, Y. Palarasah, J. S. Jørgensen, 2022, Frontiers in Medicine.

Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status

J. Jespersen, C. Kluft, J. Gram, 2000, EJIFCC.

Multicentre Evaluation of Commercial Kit Methods: Plasminogen Activator Inhibitor Activity

P. Declerck, J. Jespersen, C. Kluft, 1993, Thrombosis and Haemostasis.

Activation of blood coagulation in pigs following lower limb gunshot trauma

J. Ingemann Jensen, J. Gram, A. Münster, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effects of inhaled plasminogen activator on the balance between coagulation and fibrinolysis in traumatized pigs

J. Ingemann Jensen, J. Gram, J. Sidelmann, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.

O. Pedersen, A. Vaag, H. Parving, 2008, European journal of endocrinology.

A Common Calibrator Does Not Secure Harmonisation of Commercial t-PA and PAI-1 Antigen Measurements

J. Jespersen, C. Kluft, M. D. de Maat, 2001, EJIFCC.

[The Scandinavian Simvastatin Survival Study (4S)].

J. Gram, 1995, Ugeskrift for laeger.

Multicenter Evaluation of Commercially Available Methods for the Immunological Determination of Plasminogen Activator Inhibitor-1 (PAI-1)

P. Declerck, J. Jespersen, C. Kluft, 1993, Thrombosis and Haemostasis.

Inflammation in atherosclerosis and acute coronary syndromes

J. Gram, 2002 .

Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction.

J. Jespersen, C. Kluft, J. Gram, 1992, Agents and actions. Supplements.

The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study.

J. Jespersen, J. Gram, J. Nielsen, 2000, Scandinavian Journal of Urology and Nephrology.

von Willebrand Factor and Prekallikrein in Plasma Are Associated With Thrombus Volume in Abdominal Aortic Aneurysms

L. Lönn, H. Sillesen, J. Goetze, 2016, Vascular and Endovascular Surgery.

Intraoperative blood loss during orthognathic surgery is predicted by thromboelastography.

J. Gram, J. Sidelmann, J. Thorn, 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Improved assay of antithrombin-III. Effects of certain additives on thrombin and on chromogenic peptide substrates.

J. Jespersen, J. Gram, 1985, Clinical chemistry.

Carotid plaque composition by CT angiography in asymptomatic subjects: a head-to-head comparison to ultrasound

D. Dey, B. Nørgaard, J. Gram, 2019, European Radiology.

Plasma histidine-rich glycoprotein and plasminogen in patients with liver disease.

J. Jespersen, J. Gram, K. Bentsen, 1985, Thrombosis research.

Intraperitoneal Heparin Ameliorates the Systemic Inflammatory Response in PD Patients

J. Jespersen, J. Gram, R. Smith Pedersen, 2005, Nephron Clinical Practice.

Gynecomasty: histological aspects in a surgical material.

J. Andersen, J. Gram, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFRCT

D. Dey, M. Olsen, J. Gram, 2020, Diabetes & vascular disease research.

High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes

D. Dey, M. Olsen, J. Gram, 2017, Diabetes & vascular disease research.

Factor VII-activating protease in patients with acute deep venous thrombosis.

F. Vitzthum, J. Jespersen, J. Gram, 2008, Thrombosis research.

Factor VII-activating protease: sex-related association with coronary artery calcification

F. Vitzthum, B. Nørgaard, J. Gram, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.

F. Vitzthum, J. Jespersen, C. Kluft, 2011, Thrombosis research.

Analytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood.

Jørgen Jespersen, Jørgen Gram, J. Jespersen, 2010, Thrombosis research.

Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome

D. Glintborg, M. Andersen, J. Gram, 2020, Acta obstetricia et gynecologica Scandinavica.

Sex difference in clot lysability and association to coronary artery calcification

B. Nørgaard, J. Gram, N. Sand, 2018, Biology of Sex Differences.

The effect of gliclazide on plasma urokinase-related fibrinolysis. The results from an exploratory study

G. Dooijewaard, J. Jespersen, C. Kluft, 1994 .

Concentration changes during venous occlusion of proteins with affinity for extracellular matrix in insulin-dependent diabetes mellitus A sign of vascular damage in patients with diabetic nephropathy?

P. Rossing, J. Jespersen, C. Kluft, 1999 .

J. Henriksen, V. Siersma, J. Gram, 2011, Scandinavian journal of primary health care.

Contact activated kallikrein generation is reduced six months after gastric bypass.

B. Gram, C. Juhl, E. Bladbjerg, 2021, Thrombosis research.

Aerosolized urokinase in pulmonary fibrosis.

J. Gram, J. Sidelmann, A. Münster, 2004, American journal of respiratory and critical care medicine.

Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients

J. Gram, M. Bor, Tummas Justinussen, 2023, Research and practice in thrombosis and haemostasis.

Orthognathic Surgery-Induced Fibrinolytic Shutdown Is Amplified by Tranexamic Acid.

J. Gram, J. Sidelmann, J. Thorn, 2020, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

PGM Guidelines for Description of Criteria and Methods for Testing of Specificity of Assay Methods for Quantities in the Fibrinolytic System

C. Francis, P. Declerck, J. Jespersen, 2000, EJIFCC.

Influence of blood handling on determination of plasma resistance against activated protein C

J. Jespersen, J. Gram, J. Sidelmann, 1996 .

Absence of Prothrombin Mutation in Inuit (Greenland Eskimos)

J. Jespersen, M. D. de Maat, E. Bladbjerg, 1998, Thrombosis and Haemostasis.

Fast form alpha-2-macroglobulin - A marker for protease activation in plasma exposed to artificial surfaces.

K. Skjoedt, J. Gram, Y. Palarasah, 2017, Clinical biochemistry.

Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study

M. Bech, A. Hermann, J. Gram, 2011, Osteoporosis International.

Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study

D. Glintborg, E. Bladbjerg, J. Gram, 2023, Endocrine connections.

ELISA for determination of total coagulation factor XII concentration in human plasma.

J. Gram, C. Koch, J. Sidelmann, 2013, Journal of immunological methods.